YORVIPATH® (palopegteriparatide) is now registered by the Therapeutic Goods Administration (TGA) for the treatment of chronic hypoparathyroidism in adults1
ROCKVILLE,Md.,Feb. 20,2025--Xiao-I Corporation (NASDAQ: AIXI),a trailblazer in artificial intelligence,today launched tAIkbox 1 in the U.S.,a game-changing AI-powered device set to redefine customer s
Clinicians can now access evidence-based clinical content live during consultations via the Corti Assistant app
SINGAPORE and TOKYO,Feb. 19,2025-- In connection with the ongoing Smart Energy Week 2025 - H2 & FC EXPO in Tokyo,Hydrexia SingaporePte Ltd.,a wholly owned company of Hydrexia Holding Limited(Hydr
Bhagat\'s new position will focus on aligning the company\'s regional strategies with its global vision
CHENGDU,China,Feb. 19,2025--BGM GroupLtd.(Nasdaq: BGM) announced the establishment of the "Duxiaobao Management Committee," which will be fully responsible for the management and decision-ma
